Entecavir and peginterferon

DRUG2 trials

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions

Hepatitis B

Phase 3

Entecavir/Pegylated Interferon in Immune Tolerant Children With Chronic Hepatitis B Virus (HBV) Infection

CompletedNCT01368497

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Hepatitis B

Start: 2012-09-30End: 2016-12-23Updated: 2022-05-26

Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B

TerminatedNCT01369199

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Hepatitis B

Start: 2012-05-31End: 2017-02-14Updated: 2022-05-26